Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.4.1 (
myosin ATPase
)
1,140
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hearts of genetically myopathic male hamsters (BIO 53 : 58) were studied at 1 month, 2 months, 3 months, 4 to 5 months and 7 months of age. The time course of alterations in the cardiac myofibrillar ATPase activity, the relationship of myofibrillar ATPase activity to free [Ca2+],
myosin ATPase
activity and the distribution of heavy chain myosin isoenzymes were evaluated. Mg2+-Ca2+ ATPase activity of cardiac myofibrils in myopathics was increased in 4 month and 7 month-old hamsters. Elevated Mg2+ ATPase activity was found as early as in 2-month-old hamster. However, there was no loss in the regulation of the myopathic myofibrillar assembly as measured by the PCa response (10(-7) M to 10(-4) M Ca2+). Scans of SDS electrophoresis slab gels of cardiac myofibrillar proteins from control (C) and myopathic animals (M) did not show any differences at any age group (1, 4 and 7 months). There was a significant decrease in myosin Ca2+ ATPase activity and actin activated Mg2+-ATPase activity at 4 to 5 months and 7 months of age in the myopathic hearts. At all ages in normal and myopathic animals cardiac myosin consisted of three isoenzymes, V1, V2 and V3. At all ages in controls and at 1 to 3 months in myopathics, V1 predominated and the isoenzyme distribution was V1 greater than V2 greater than V3. However, in myopathics at 4 to 5 months, the distribution was V1 = V3 greater than V2 and at 7 months was V3 greater than V2 greater than V1. Our experiments suggest alterations in different components of the contractile protein system that occur at different stages of myopathy.
J Mol Cell
Cardiol
1985 Feb
PMID:Multiple cardiac contractile protein abnormalities in myopathic Syrian hamsters (BIO 53 : 58). 315 46
Myosin of the ventricular myocardium of the cardiomyopathic Syrian hamster and of control animals was analysed using non-dissociating pyrophosphate electrophoresis. Three different myosin isoenzymes exhibiting different Ca2+ activated ATPase activities were demonstrated in the ventricular myocardium of the Syrian hamster. As shown by peptide mapping, ventricular myosin isoenzymes differ in their heavy chain composition. In the cardiomyopathic hamster a shift to myosins of lower Ca2+-activated ATPase activities occurs in the stage of insufficiency (age 220 days), whereas no different isoenzyme pattern could be found at the age of 65 days compared to control animals. We conclude that this redistribution of myosin isoenzymes is the basis of reduced
myosin ATPase
activity in the ventricular myocardium of the cardiomyopathic Syrian hamster during the development of myocardial insufficiency.
Basic Res
Cardiol
PMID:Altered distribution of myosin isoenzymes in the cardiomyopathic Syrian hamster (BIO 8.262). 622 45
The decrease in
myosin ATPase
activity observed in cardiac hypertrophy induced by cardiac overload has been related to an isoenzymic redistribution of myosin. To test the hypothesis of an additional regulation of
myosin ATPase
through light chain phosphorylation, we measured the myosin kinase activity together in sham-operated and 50% to 100% hypertrophied rat hearts. The myosin kinase were purified approximately 600 fold with 6% yield by ion exchange chromatography and calmodulin-affinity chromatography. The presence of very important levels of proteolytic activity in the rat heart resulted in a partial loss of the myosin kinase calmodulin-dependency. The major component from both myosin kinase purified fractions was a 63 kdaltons protein. The protein content was identical in myosin kinase purified fractions from sham-operated and hypertrophied hearts. The calmodulin-dependent activity of myosin kinase, assayed in the presence of 0.1 mM Ca2+ and 10(-6) M calmodulin (about 6.6 nmol P X min-1 X mg-1), was identical in sham-operated and 50% to 100% hypertrophied hearts. Thus, myosin kinase specific activity, in these conditions, was unchanged in rat heart chronic hypertrophy. This result suggests that no direct functional relationship exists between the enzymatic properties of myosin and myosin kinase during the chronic phase of cardiac hypertrophy.
J Mol Cell
Cardiol
1984 Nov
PMID:Unchanged myosin kinase activity in hypertrophied rat heart. 624 May 42
The effects of running training on the structure and function of ventricular myosin of guinea-pigs were studied. No differences in body or heart weights could be detected but the heart-to-body weight relation increased significantly (P less than 0.05) in the trained group. Ca2+ activated and K+ activated ventricular
myosin ATPase
activities as well as the electrophoretic appearances (SDS-PAGE, pyrophosphate-PAGE) did not change after training. Guinea-pig ventricular myosin in nondissociating conditions showed one band migrating close to rat-V3 isomyosin. The myosins of the trained and untrained animals also showed no immunological difference as determined by the competitive ELISA-test: they both shared antigenic determinants common to rat-V1 isomyosin.
J Mol Cell
Cardiol
1984 Mar
PMID:Effects of treadmill running on the properties of guinea-pig myosin. 632 14
The incidence of mortality from cardiovascular diseases in higher in diabetic patients. The cause of this accelerated cardiovascular disease is multifactorial and, although atherosclerotic cardiovascular disease in association with well-defined risk factors has an influence on morbidity and mortality in diabetics, myocardial cell dysfunction independent of vascular defects have also been defined. We postulate that these adverse cardiac effects could presumably result as a consequence of the following sequence of events. Major abnormalities in myocardial carbohydrate and lipid metabolism occur as a result of insulin deficiency. These changes are closely linked to the accumulation of various acylcarnitine and coenzyme derivatives. Abnormally high amounts of metabolic intermediates could cause disturbances in calcium homeostasis either directly or indirectly through structural and functional subcellular membrane alterations. Over time, chronic abnormalities such as reduced
myosin ATPase
activity, decreased ability of the sarcoplasmic reticulum to take up calcium as well as depression of other membrane enzymes such as Na(+)-K+ ATPase and Ca(2+)-ATPase leads to changes in calcium homeostasis and eventually to cardiac dysfunction. More importantly from the point of view of pharmacological intervention, during the initial stages, acute disturbances in both the glucose and FFA oxidative pathways may provide the initial biochemical lesion from which further events ensue. Thus therapies which target these metabolic aberrations in the heart during the early stages of diabetes, in effect, can potentially delay or impede the progression of more permanent sequelae which could ensue from otherwise uncontrolled derangements in cardiac metabolism. There is little dispute that an attempt should be made to lower raised plasma triglyceride and FFA levels. This would decrease the heart's reliance on fatty acids and, hence, overcome the fatty acid inhibition of myocardial glucose utilization. In this regard, the likely application of fatty acid oxidation inhibitors (CPT inhibitors, beta-oxidation inhibitors, sequestration of mitochondrial CoA) is also apparent.
J Mol Cell
Cardiol
1995 Jan
PMID:Myocardial substrate metabolism: implications for diabetic cardiomyopathy. 776 Mar 40
A new contractility index (Ec) is proposed based on the slope of the left ventricular (LV) end-systolic force-length relationship. The Ec values of normal human hearts are relatively constant. The present study investigated the Ec values of 16 cases of heart failure in 11 patients with old myocardial infarction and 5 with dilated cardiomyopathy in NYHA functional class 1 to 3. The LV end-systolic pressure (Pes) and dimension (Des) were estimated simultaneously by intraarterial cannulation and LV echocardiography. The LV pressure decreased from 111 +/- 17 to 90 +/- 14 mmHg after intravenous infusion of nitroglycerin. The LV Fes-Des relationship was found to be nearly linear and the slope (Ec) and extrapolated dimension intercepts (Do) were obtained as 60 +/- 22 g/cm and 2.7 +/- 1.2 cm, respectively. The values of Ec and Do were both proportional to the baseline Des value. Our model predicts that the Ec value reflects intracellular peak Ca2+ concentrations ([Ca2+]) of the myocardium and/or
myosin ATPase
activity. The present results suggest that the working myocardium of a failing heart increases [Ca2+] and/or
myosin ATPase
activity to compensate for depressed LV pump function due to myocardial damage.
J
Cardiol
1993
PMID:[The left ventricular force-length relationship in patients with heart failure]. 806 87
Adaptive cardiac hypertrophy in the rat has been characterized as pathological or physiological reflecting the nature of the inciting stimulus. These two adaptations are distinguished by alterations in contractility and in the
myosin ATPase
composition of the affected muscle. We investigated the relative amounts of the mRNAs encoding cardiac sarcoplasmic reticular calcium ATPase (SERCA2), cardiac and skeletal troponin I (TnI), atrial natriuretic factor (ANF), and myosin light chain 1 (MLC1) in the hearts of rats that had been subjected to either conditioning by swimming (Sw), to renovascular hypertension (H) or to the combined stimulus (H-Sw) for 6 weeks. Compared to control animals, the mRNA levels for SERCA2 and cardiac TnI were slightly increased with Sw and moderately depressed with H. H-Sw animals showed a trend towards normalized mRNA levels for both genes. ANF mRNA levels were slightly elevated with Sw and markedly elevated with both H and H-Sw. MLC1 mRNA levels did not change with either or both stimuli. These data confirm that these two types of adaptive hypertrophy can be distinguished at the level of gene expression and suggest that the mechanical alterations seen in adaptive hypertrophy reflect a spectrum of pre-translational alterations which are not limited to changes in myosin heavy chain gene expression.
J Mol Cell
Cardiol
1994 Jan
PMID:Alterations in gene expression in the rat heart after chronic pathological and physiological loads. 819 70
It has been suggested that the length dependence of myofilament Ca2+ sensitivity and of Ca2+ binding to troponin C, observed over the ascending limb of the cardiac force-length curve, is based on variation in the number of interacting cross-bridges. This interaction would be reduced at short sarcomere length as a consequence of double overlap of oppositely polarized actin filaments and increased lateral separation of actin and myosin filaments. Based on current evidence, it is not clear to what extent the actin-myosin interaction is hindered at sarcomere lengths where Ca2+ sensitivity is reduced. We have used two biochemical assays to assess cross-bridge attachment in rigor muscle at sarcomere lengths corresponding to the ascending limb of the cardiac force-length curve. These are based on (1) the inhibition of K+-activated
myosin ATPase
by the complexation of actin with myosin, and (2) the enhancement of Ca2+ binding to troponin C by rigor bridge attachment to actin. Measurements were made with skinned fibers from bovine ventricle. As a check on our method, measurements were also made with skinned rabbit psoas muscle fibers. With both muscle types, a reduction in sarcomere length along the ascending limb of the force-length curve was associated with an increase in K+-activated ATPase activity and a reduction in Ca2+ binding to the regulatory sites of troponin C. These results indicate that actin-myosin interaction is significantly reduced at short sarcomere length.
J Mol Cell
Cardiol
1997 Dec
PMID:Length-dependence of actin-myosin interaction in skinned cardiac muscle fibers in rigor. 944 32
Ischaemic myocardium undergoes calcium-independent contracture at millimolar tissue ATP, though in actomyosin solutions ATP must be reduced to micromolar before rigor complexes form. This contracture is associated with
myosin ATPase
activity that may contribute to tissue de-energization. Here we used isolated rat cardiomyocytes permeabilized with digitonin to analyse in parallel how rigor and
myosin ATPase
activity are modulated by metabolic conditions that develop during ischaemia. At pH 7.1 and 37 degrees C rigor and
myosin ATPase
showed co-ordinated bell-shaped dependence on ATP concentration over 3-1000 microM. Rigor, but not
myosin ATPase
, was inhibited by acidosis (pH 6.2), indicating reduced efficiency of cross-bridge cycling, while both parameters were stimulated by ADP (< or = 1 mM) and unaffected by inorganic phosphate (Pi, 30 mM), AMP, Mg2+, lactate or inhibition of adenylate kinase with diadenosine pentaphosphate. Combined acidosis and high ADP inhibited rigor, while Pi attenuated the enhancement of rigor by ADP. Thus, rigor complex formation activates
myosin ATPase
in the intact myofilament array, modulated by ADP, Pi and acidosis in the ranges that occur in ischaemia. There was no evidence that adenylate kinase might attenuate falling ATP/ADP ratio at the myofilaments. In combination these effects are sufficient to resolve the apparent discrepancy between ATP concentrations triggering rigor in actomyosin and onset of contracture in ischaemic myocardium. Since rigor contracture activates
myosin ATPase
it is likely to exacerbate ATP depletion and thereby limit vital cell functions. This positive feedback is consistent with the abrupt depletion of ATP observed in individual cardiomyocytes undergoing deenergization contracture.
J Mol Cell
Cardiol
1998 Jul
PMID:Modulation of rigor and myosin ATPase activity in rat cardiomyocytes. 971 Aug 3
Alcoholic heart muscle disease is characterized by structural changes which include chamber dilation, ventricular hypertrophy, and myocyte damage. These effects often lead to contractile dysfunction and ultimately to heart failure if alcohol consumption is not terminated. In rat models for heart failure in which heart failure is induced by pressure or volume overload, there is a shift in the myosin heavy chain (MHC) isoforms, from alpha to beta. As a result of this MHC transition, there is typically a decrease in
myosin ATPase
activity. We utilized a rat model of chronic alcohol consumption in order to determine if alcohol causes a similar shift in MHC isoforms and changes in
myosin ATPase
activity. A liquid diet containing 9% ethanol (46% of daily calories; 11.8 g/kg/day) was administered to adult rats for a period of 60 or 90 days. This heavy consumption of ethanol resulted in an average blood ethanol content of 150 mg %. The relative abundance of beta-MHC isoform protein increased from a control level of 9.7% to 35.1% in hearts of ethanol-fed rats, following 90 days of ethanol consumption. In a separate set of experiments, the levels of alpha-MHC and beta-MHC mRNA were demonstrated to increase by 150% and 230%, respectively. Following a 60 day treatment, there was a significant reduction in the actomyosin Mg2+ -ATPase activity in the myofibrillar preparations from hearts of ethanol-fed rats compared to hearts from control-fed rats. In addition, the myosin Ca2+ -ATPase activity was decreased 17% and 30% after 60 and 90 days of ethanol consumption, respectively. The present study demonstrates that chronic ethanol consumption induces an increase in the proportion of the total MHC content composed of the beta-isoform. This isoform transition is accompanied by an accumulation of beta-MHC mRNA, suggesting that the switch is organized pretranslationally. A functional consequence of this transition in MHC phenotype is demonstrated by significant decreases in the myofibrillar and
myosin ATPase
activities.
Basic Res
Cardiol
1999 Dec
PMID:Heavy long-term ethanol consumption induces an alpha- to beta-myosin heavy chain isoform transition in rat. 1065 Nov 60
<< Previous
1
2
3
4
Next >>